Instem

Instem CapEx/OCF

Delisted

The CapEx to Operating Cash Flow Ratio of Instem (INS.L) as of Nov 22, 2026 is 44.64 %. In the previous year, CapEx to Operating Cash Flow Ratio was 25.87 % — a change of 72.55% (higher).

CapEx/OCF

44.64 %

YoY

72.55%

Last updated:

CapEx to Operating Cash Flow Ratio of Instem is 2022 44.64 % . CapEx to Operating Cash Flow Ratio of Instem was 2021 25.87 % . It decreases by 72.55% higher compared to the previous year.

The Instem CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2015
29.20 GBP
Jan 1, 2016
769.23 GBP
Jan 1, 2017
117.27 GBP
Jan 1, 2018
74.55 GBP
Jan 1, 2019
26.57 GBP
Jan 1, 2020
20.32 GBP
Jan 1, 2021
25.87 GBP
Jan 1, 2022
44.64 GBP
The Instem CapEx/OCF history
YEARCapEx/OCFYoY
44.64 %+72.55%
25.87 %+27.33%
20.32 %-23.53%
26.57 %-64.36%
74.55 %-36.43%
117.27 %-84.76%
769.23 %+2,534.35%
29.20 %-71.40%
102.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instem Stock analysis

What does Instem do? Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instem stock

CapEx to Operating Cash Flow Ratio of Instem is 44.64 % in 2022.

CapEx to Operating Cash Flow Ratio of Instem changed from 25.87 % to 44.64 %, representing a 72.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Instem since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Instem with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Instem

All Key Metrics — Instem